AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference on Wednesday, May 13, 2026 at 10:00 a.m. PT.
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference on Wednesday, May 13, 2026 at 10:00 a.m. PT. Presenters are Peter Griffith (EVP & CFO) and Jay Bradner (EVP, R&D). The presentation will be webcast and archived for at least 90 days.
Webcast access, timing and links are available on Amgen's Investor Relations Events Calendar on the company website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AMGN
On May 8, the first trading day after this news, AMGN closed 0.79% above the previous close.
Data tracked by StockTitan Argus for the May 8 session.
Key Figures
- Conference time
- 10:00 a.m. PT
- Scheduled presentation at Bank of America Merrill Lynch Global Healthcare Conference
- Conference date
- May 13, 2026
- Date of Amgen’s presentation at the conference
- Webcast archive period
- at least 90 days
- Length of time the conference webcast will be available for replay
Historical Context
-
Announced additional U.S. biologics manufacturing investment totaling nearly $2B over year.
-
Clarified Q1 2026 revenues, EPS and guidance details following initial earnings release.
-
Reported Q1 revenue growth, EPS increases, strong margins and full‑year 2026 guidance.
-
Announced timing and webcast details for the first quarter 2026 financial results call.
-
Announced CTO retirement and organizational changes integrating biology, data science and AI.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks,
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-bank-of-america-merrill-lynch-global-healthcare-conference-302766201.html
SOURCE Amgen
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
